Biological restoration of central nervous system architecture and function: part 3-stem cell- and cell-based applications and realities in the biological management of central nervous system disorders: traumatic, vascular, and epilepsy disorders - PubMed (original) (raw)
Review
Biological restoration of central nervous system architecture and function: part 3-stem cell- and cell-based applications and realities in the biological management of central nervous system disorders: traumatic, vascular, and epilepsy disorders
Azadeh Farin et al. Neurosurgery. 2009 Nov.
Abstract
STEM CELL THERAPY has emerged as a promising novel therapeutic endeavor for traumatic brain injury, spinal cord injury, stroke, and epilepsy in experimental studies. A few preliminary clinical trials have further supported its safety and early efficacy after transplantation into humans. Although not yet clinically available for central nervous system disorders, stem cell technology is expected to evolve into one of the most powerful tools in the biological management of complex central nervous system disorders, many of which currently have limited treatment modalities. The identification of stem cells, discovery of neurogenesis, and application of stem cells to treat central nervous system disorders represent a dramatic evolution and expansion of the neurosurgeon's capabilities into the neurorestoration and neuroregeneration realms. In Part 3 of a 5-part series on stem cells, we discuss the theory, experimental evidence, and clinical data pertaining to the use of stem cells for the treatment of traumatic, vascular, and epileptic disorders.
Similar articles
- The biological restoration of central nervous system architecture and function: part 1-foundations and historical landmarks in contemporary stem cell biology.
Farin A, Liu CY, Elder JB, Langmoen IA, Apuzzo ML. Farin A, et al. Neurosurgery. 2009 Jan;64(1):15-39; discussion 34. doi: 10.1227/01.NEU.0000337580.02706.DC. Neurosurgery. 2009. PMID: 19145154 Review. - Therapeutic potential of stem cells in central nervous system regeneration.
Webber DJ, Minger SL. Webber DJ, et al. Curr Opin Investig Drugs. 2004 Jul;5(7):714-9. Curr Opin Investig Drugs. 2004. PMID: 15298066 Review. - Neuroprotection in traumatic brain injury.
Jain KK. Jain KK. Drug Discov Today. 2008 Dec;13(23-24):1082-9. doi: 10.1016/j.drudis.2008.09.006. Epub 2008 Oct 22. Drug Discov Today. 2008. PMID: 18848641 Review. - The changing face of neural stem cell therapy in neurologic diseases.
Einstein O, Ben-Hur T. Einstein O, et al. Arch Neurol. 2008 Apr;65(4):452-6. doi: 10.1001/archneur.65.4.452. Arch Neurol. 2008. PMID: 18413466 Review. - Cell replacement therapies for central nervous system disorders.
Björklund A, Lindvall O. Björklund A, et al. Nat Neurosci. 2000 Jun;3(6):537-44. doi: 10.1038/75705. Nat Neurosci. 2000. PMID: 10816308 Review.
Cited by
- The great migration of bone marrow-derived stem cells toward the ischemic brain: therapeutic implications for stroke and other neurological disorders.
Borlongan CV, Glover LE, Tajiri N, Kaneko Y, Freeman TB. Borlongan CV, et al. Prog Neurobiol. 2011 Oct;95(2):213-28. doi: 10.1016/j.pneurobio.2011.08.005. Epub 2011 Aug 30. Prog Neurobiol. 2011. PMID: 21903148 Free PMC article. Review. - The emerging role of epigenetics in stroke: III. Neural stem cell biology and regenerative medicine.
Qureshi IA, Mehler MF. Qureshi IA, et al. Arch Neurol. 2011 Mar;68(3):294-302. doi: 10.1001/archneurol.2011.6. Arch Neurol. 2011. PMID: 21403016 Free PMC article. Review. - Bone marrow stem cell mobilization in stroke: a 'bonehead' may be good after all!
Borlongan CV. Borlongan CV. Leukemia. 2011 Nov;25(11):1674-86. doi: 10.1038/leu.2011.167. Epub 2011 Jul 5. Leukemia. 2011. PMID: 21727900 Free PMC article. Review. - Therapeutic potential of endothelial progenitor cells in a rat model of epilepsy: Role of autophagy.
Ali SO, Shahin NN, Safar MM, Rizk SM. Ali SO, et al. J Adv Res. 2019 Jan 31;18:101-112. doi: 10.1016/j.jare.2019.01.013. eCollection 2019 Jul. J Adv Res. 2019. PMID: 30847250 Free PMC article. - Evidence that the population of quiescent bone marrow-residing very small embryonic/epiblast-like stem cells (VSELs) expands in response to neurotoxic treatment.
Grymula K, Tarnowski M, Piotrowska K, Suszynska M, Mierzejewska K, Borkowska S, Fiedorowicz K, Kucia M, Ratajczak MZ. Grymula K, et al. J Cell Mol Med. 2014 Sep;18(9):1797-806. doi: 10.1111/jcmm.12315. Epub 2014 Jun 4. J Cell Mol Med. 2014. PMID: 24895014 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical